-
-
-
-
-
-
-
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
-
-
-
-
-
-
-
Ironwood Pharma (IRWD) Misses Q3 EPS by 5c ; Offers Guidance
-
-
-
-
-
-
-
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
-
-
-
-
-
-
-
Ironwood Pharma (IRWD) Misses Q1 EPS by 1c; Offers FY23 Revenue Guidance
-
-
-
-
-
-
-
Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
-
-
-
-
-
-
-
Ironwood Pharma (IRWD) Tops Q3 EPS by 2c
-
-
-
-
-
-
-
Ironwood Pharma (IRWD) Tops Q1 EPS by 3c, Revenues Miss; Offers FY21 Revenues Guidance Above Consensus
-
1,202,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

